Welcome to the
Hepatitis B Foundation
Intradermal HBV Vaccine Appears Safe, Effective for Intramuscular Nonresponders
June 29 - For intramuscular hepatitis B virus vaccine nonresponders, intradermal vaccine administration seems efficacious and safe, according to a study published online June 23 in the Journal of Gastroenterology and Hepatology. Read more.
ABIVAX: a New Weapon in the Fight Against Hepatitis B
June 29 – A new therapeutic vaccine for chronic hepatitis B currently in clinical trials in Asia Pacific could revolutionize the treatment of the disease. Read more.
Does Hepatocellular Carcinoma Differ in People with Hepatitis B and C?
June 29 – Liver cancer patients with hepatitis B at a large U.S. cancer center appeared to have worse disease status than those with hepatitis C, including larger tumors and more extensive liver involvement, according to research presented at the American Society of Clinical Oncology (ASCO) annual meeting this month in Chicago. Read more.
New Prescribing and Dispensing Arrangements Make GPs Central to the Response to Hepatitis B
June 29 – New arrangements for the prescribing and dispensing of medicines for people living with chronic hepatitis B in Australia will go into effect July 1, 2015, improving access to antiviral treatment. Read more.
In this CME Outfitters Live and On Demand panel discussion, national experts will provide strategic education to primary care providers who manage patients with chronic HBV. They will discuss screening, interpretation of blood tests, and care for those undergoing treatment with the goal of optimizing long-term patient outcomes. This activity will be available as an archive for one year after the live webinar at www.cmeoutfitters.com/activities.asp.
Institute Assembles Team of 'All-Star Researchers' to Cure Hepatitis B
April 6– The Baruch S. Blumberg Institute has recruited a new team of nationally renowned, “all Star researchers” who will focus exclusively on developing a cure for hepatitis B, with a goal for breakthrough therapies within the next three years. Read more.
Page last modified June 29, 2015